25 EXHIBITORS AT CPHI MILAN 2024 Ypsomed AG Booth 20F25 With 40 years of experience and extensive know-how, Swiss-based Ypsomed offers a comprehensive platform product portfolio, encompassing the broadest range of self-injection devices available on the market. This portfolio is tailored to meet a broad spectrum of therapeutic needs for the treatment of chronic conditions. The portfolio includes autoinjec- tors for prefilled syringes, prefilled and reusable pen injectors, and patch injectors, designed for volumes up to 10 mL. Leveraging its extensive expertise, Ypsomed’s modular platform technologies enable rapid customization, minimizing project risks and reducing time to market. While expanding its global presence with manufacturing sites in Switzer- land, China, Germany and North America, Ypsomed continues to uphold the Swiss tradition of precision engineering and high quality across all its products. In addition to its platform capabilities, Ypsomed is at the forefront of digital health innovation. The company has in- vested in the development of connected injection devices and comprehensive digital patient tools to enhance therapy management. Ypsomed’s Digital Health solutions aim to improve patient adherence, support clinical trials, and acce- lerate market access by integrating smart device technologies that provide valuable real-world data. With seamless connectivity and robust data management, Ypsomed’s Digital Health platform supports both patients and pharmaceu- tical companies in optimizing therapeutic outcomes and driving competitive advantage. Ypsomed also addresses sustainability through its NetZero Program, an ambitious roadmap aiming for net zero carbon emissions by 2040. This commitment includes developing carbon-reduced products and implementing sustainable practices across the entire value chain. The prefilled YpsoMate and UnoPen platform are already part of the NetZero Program using carbon friendly components and packaging trays. In 2023, Ypsomed introduced a new reusable autoin- jector concept, a sustainable innovation that minimizes waste through a reusable drive unit and a simple, single-use bioplastic-based cassette design which hides the needle and provides needle safety after the injection has been com- pleted. Through its strong platform portfolio, commitment to digital health, and sustainability approach, Ypsomed continues to empower patients and support its partners worldwide, making self-care simpler and easier, and delivering trusted solutions that advance the future of healthcare.